Sutro Biopharma
STRO
#9292
Rank
HK$1.11 B
Marketcap
HK$67.41
Share price
-1.38%
Change (1 day)
931.23%
Change (1 year)

EPS for Sutro Biopharma (STRO)

EPS in 2026 (TTM): -HK$104.45

According to Sutro Biopharma's latest financial reports the company's current EPS (TTM) is -HK$104.80. In 2025 the company made an earnings per share (EPS) of -HK$176.29 an increase over its 2024 EPS that were of -HK$230.45.

EPS history for Sutro Biopharma from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$104.45-40.75%
2025-HK$176.29-23.5%
2024-HK$230.4565.17%
2023-HK$139.53-24.26%
2022-HK$184.212.62%
2021-HK$179.50131.31%
2020-HK$77.60-59.26%
2019-HK$190.48-60.36%
2018-HK$480.51117.87%
2017-HK$220.55
2016N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-HK$1.49-98.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$7.45-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA